Article
Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.
Molecular neurobiology - 1 May 2018
Cunha Carolina, Santos Catarina, Gomes Cátia, Fernandes Adelaide, Correia Alexandra Marçal, Sebastião Ana Maria, Vaz Ana Rita, Brites Dora
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of unknown cause. Absence of specific targets and biomarkers compromise the development of new therapeutic strategies and of innovative tools to stratify patients and assess their responses to treatment. Here, we investigate changes in neuroprotective-neuroinflammatory actions in the spinal cord of SOD1 G93A mice, at presymptomatic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
